Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.

Literature DB >> 21219413

Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.

Thomas Wendland, Barbara Daubner, Werner J Pichler.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 21219413 PMCID： PMC3040553 DOI： 10.1111/j.1365-2125.2010.03832.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

19 in total

1. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis.

Authors: A Kindmark; A Jawaid; C G Harbron; B J Barratt; O F Bengtsson; T B Andersson; S Carlsson; K E Cederbrant; N J Gibson; M Armstrong; M E Lagerström-Fermér; A Dellsén; E M Brown; M Thornton; C Dukes; S C Jenkins; M A Firth; G O Harrod; T H Pinel; S M E Billing-Clason; L R Cardon; R E March
Journal: Pharmacogenomics J Date: 2007-05-15 Impact factor: 3.550

2. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis.

Authors: B H CHAIKEN; B I GOLDBERG; J P SEGAL
Journal: N Engl J Med Date: 1950-06-08 Impact factor: 91.245

Review 3. Reactive metabolites and agranulocytosis.

Authors: J P Uetrecht
Journal: Eur J Haematol Suppl Date: 1996

Review 4. [Beta-lactam-induced neutropenia. An old forgotten companion].

Authors: Galo Peralta; María Blanca Sánchez-Santiago
Journal: Enferm Infecc Microbiol Clin Date: 2005-10 Impact factor: 1.731

5. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.

Authors: Ying Wu; John Farrell; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal: J Allergy Clin Immunol Date: 2007-02-22 Impact factor: 10.793

Review 6. Systematic review: agranulocytosis induced by nonchemotherapy drugs.

Authors: Frank Andersohn; Christine Konzen; Edeltraut Garbe
Journal: Ann Intern Med Date: 2007-05-01 Impact factor: 25.391

7. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients.

Authors: Mona Ben M'rad; Stéphanie Leclerc-Mercier; Philippe Blanche; Nathalie Franck; Flore Rozenberg; Yvonne Fulla; Myriam Guesmi; Florence Rollot; Monique Dehoux; Loïc Guillevin; Laurence Moachon
Journal: Medicine (Baltimore) Date: 2009-05 Impact factor: 1.889

8. Measurement of specific IgG antibody levels in serum of patients on regimes comprising high total dose beta-lactam therapy.

Authors: D Lee; J M Dewdney; R G Edwards; K A Neftel; M Wälti
Journal: Int Arch Allergy Appl Immunol Date: 1986

Review 9. Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).

Authors: April Barbour; Stephan Schmidt; Kenneth H Rand; Hartmut Derendorf
Journal: Int J Antimicrob Agents Date: 2009-03-03 Impact factor: 5.283

10. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.

Authors: Gary J Noel; Karen Bush; Partha Bagchi; Juliana Ianus; Richard S Strauss
Journal: Clin Infect Dis Date: 2008-03-01 Impact factor: 9.079

5 in total

Review 1. Multiple Drug Hypersensitivity.

Authors: Werner J Pichler; Yuttana Srinoulprasert; James Yun; Oliver Hausmann
Journal: Int Arch Allergy Immunol Date: 2017-03-18 Impact factor: 2.749

Review 5. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.

Authors: Shiva Sharifzadeh; Amir Hooshang Mohammadpour; Ashraf Tavanaee; Sepideh Elyasi
Journal: Eur J Clin Pharmacol Date: 2020-10-06 Impact factor: 2.953